Sanofi said to weigh alternative deals to Medivation; eyes BioMarin pharmaceutical - sources - part 2

Now, I wonder what Sanofi plans to next after missing out on the US biotech business it aggresively pursued for most of this year?

You need to register and sign in to read this content.